Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118348 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
A NA study of Hypercholesterolemia and Hypercholesterolemia, Familial, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 13,340
- Enrollment target
- 1
- Study location
NCT04118348: Completed NA study of Hypercholesterolemia and Hypercholesterolemia, Familial, sponsored by Geisinger Clinic.
NCT04118348 is a NA study of Hypercholesterolemia and Hypercholesterolemia, Familial that has completed, run by Geisinger Clinic. The registered enrollment target is 13,340 participants, above the 602-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (2116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04118348, a NA study of Hypercholesterolemia and Hypercholesterolemia, Familial, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 13,340 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinations of alerts on provider prescribing behavior and patient uptake of screening.
Primary Outcome
Provider ordered a lipid panel to an eligible patient during the patient's first visit within the study period (binary variable).
Conditions Studied
Interventions
- BEHAVIORAL Best Practice Alert
- BEHAVIORAL Health Maintenance Topic
Study Locations (1)
Pennsylvania
- Geisinger Health System - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,340 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2020-10-11 |
| Phase | NA |
What the finished NCT04118348 record still lists
NCT04118348 is an interventional study that assigns participants to a tested intervention. Its 13,340 participants enrollment target places it among the larger protocols in the corpus, above the 602-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (2116% higher).
The record links to 4 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Best Practice Alert is the first listed.
NCT04118348 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04118348 about?
NCT04118348 is a clinical study titled "Evaluating the Efficacy of Pediatric Lipid Screening Alerts". The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinatio...
What is the current status of trial NCT04118348?
This trial is currently completed. It is a NA study. The enrollment target is 13,340 participants. The study started on 2019-10-10. Estimated completion is 2020-10-11.
What conditions does trial NCT04118348 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children, Hyperlipidemia in Children.
What interventions are being tested in trial NCT04118348?
The interventions under investigation include: Best Practice Alert (BEHAVIORAL), Health Maintenance Topic (BEHAVIORAL).
Who is sponsoring clinical trial NCT04118348?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04118348 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04118348's enrollment target sits among peer trials
13,340 1st of 62 higher than 62 of 62 other Hypercholesterolemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypercholesterolemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
RECRUITING · NA
-
Pharmacogenomic Informed Statin Prescribing
RECRUITING · NA
-
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
ACTIVE NOT RECRUITING · NA
-
Effect of Diabetes Mellitus on Cholesterol Metabolism
COMPLETED · NA
-
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
COMPLETED · NA
-
Diets Enriched With Pecans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- NCT07028398 · 12,990 participants · NA
CMSL Ambulatory Sensitive Condition Nudge Study 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI